{"title":"Malignant hypertension, and if it was scleroderma? Lessons from two cases.","authors":"Réda Laamech, Diane Giovannini, Etienne Cellot, Sandra Jost, Benoit Franko","doi":"10.1080/08037051.2025.2482741","DOIUrl":"10.1080/08037051.2025.2482741","url":null,"abstract":"<p><p><b>Inroduction :</b> Scleroderma Renal Crisis (SRC) is characterised by acute hypertension, haemolytic anaemia (HA), and acute kidney injury (AKI). Often presenting as the first manifestation of scleroderma, it is frequently mistaken for malignant hypertension (MHT). Rapid recognition and differentiation of SRC from other hypertensive emergencies are essential for improving patient outcomes.We present two clinical cases that illustrate the diagnostic challenges of SRC in the context of MHT.</p><p><p><b>Case 1:</b> A 53-year-old man presented with severe hypertension (238/127 mmHg) and AKI (creatinine 390 μmol/L). He was diagnosed MHT due to the presence of grade III hypertensive retinopathy and HA. . However, a urine dipstick test detected haematuria, leading to further immune testing and, a renal biopsy, which confirmed SRC. Treatment with high-dose ramipril led to a sustained recovery of kidney function, 221 μmol/L after five years).</p><p><p><b>Case 2:</b> A 52-year-old man presented with chest pain, severe hypertension (253/132 mmHg), and AKI (creatinine 183 μmol/L). Initially managed as MHT, his kidney function worsened, prompting further investigation, which revealed haematuria and positive anti-nuclear antibodies. A renal biopsy confirmed SRC. High-dose ramipril was reintroduced, leading to partial kidney function recovery (creatinine 218 μmol/L after five years).</p><p><p><b>Key findings :</b> These cases underscore the importance of early detection of hematuria and autoimmune markers to expedite diagnosis of SRC in case of MHT. When SRC is suspected, high-dose angiotensin-converting enzyme inhibitors (ACEi) should be initiated immediately, even before biopsy confirmation and continued despite initial kidney function decline. Early intervention is crucial for optimising kidney outcomes and achieving effective blood pressure control.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2482741"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143661935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-02-05DOI: 10.1080/08037051.2025.2457698
Mateusz Gaczoł, Marek Rajzer, Wiktoria Wojciechowska
{"title":"Ventricular-arterial coupling: changes with ageing and implications across cardiovascular conditions.","authors":"Mateusz Gaczoł, Marek Rajzer, Wiktoria Wojciechowska","doi":"10.1080/08037051.2025.2457698","DOIUrl":"10.1080/08037051.2025.2457698","url":null,"abstract":"<p><strong>Purpose: </strong>Ventricular-arterial coupling (VAC) is a crucial concept in cardiovascular physiology, representing the dynamic interaction between the left ventricle and the arterial system. This comprehensive literature review explores the changes in VAC with ageing and various cardiovascular diseases (CVDs).</p><p><strong>Materials and methods: </strong>This literature review covers studies on changes in VAC with age and common CVDs, such as arterial hypertension, atrial fibrillation (AF) and heart failure with preserved and reduced ejection fraction and aortic stenosis (AS). The review discusses traditional measures of VAC, including arterial elastance (Ea) and ventricular elastance (Ees), as well as emerging parameters, such as global longitudinal strain (GLS) and pulse wave velocity (PWV). The review introduces the PWV/GLS ratio as a novel method for assessing VAC.</p><p><strong>Results: </strong>With ageing, both Ea and Ees increase, while the Ea/Ees ratio remains relatively stable, reflecting balanced arterial and ventricular adaptations. Novel measures, such as PWV/GLS ratio, show greater impairment in older adults and provide a comprehensive evaluation of VAC.</p><p><strong>Conclusions: </strong>Ageing disrupts VAC through arterial stiffening and reduced heart function, often exacerbated by CVDs. Novel metrics like PWV/GLS may improve VAC assessment, helping clinicians manage age-related cardiovascular issues by identifying risks earlier and guiding treatment to support efficient heart-artery interaction.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2457698"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143021920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-02-25DOI: 10.1080/08037051.2025.2469264
Bihua Chen, Guorong Chen, Hong Jiang, Ya Sun, Jie Chen, Dan Wang, Mingzhi Chen, Jia Shi, Yan Peng, Yimin Cheng, Cheng Yang, Yuanyuan Ding, Jin Su, Ming Liu, Fulai Shen, Yicheng Qiu, Yi Shen, Qiyun Cao, Jiayu Su
{"title":"Validating the accuracy of Omron J760 electronic blood pressure monitor in the general population according to AAMI/ESH/ISO (ISO 81060-2:2018) + AMD1:2020.","authors":"Bihua Chen, Guorong Chen, Hong Jiang, Ya Sun, Jie Chen, Dan Wang, Mingzhi Chen, Jia Shi, Yan Peng, Yimin Cheng, Cheng Yang, Yuanyuan Ding, Jin Su, Ming Liu, Fulai Shen, Yicheng Qiu, Yi Shen, Qiyun Cao, Jiayu Su","doi":"10.1080/08037051.2025.2469264","DOIUrl":"10.1080/08037051.2025.2469264","url":null,"abstract":"<p><strong>Purpose: </strong>The accuracy of the Omron J760 electronic blood pressure (BP) monitor for upper arm BP measurement in the adult general population was validated following the AAMI/ESH/ISO (ISO 81060-2:2018) + Amd1:2020 protocol. We expect that this device can be used for home blood pressure monitoring, with its measurements serving as a clinical reference.</p><p><strong>Methods: </strong>Subjects meeting the age, gender, BP, and cuff distribution criteria as specified by the AAMI/ESH/ISO (ISO 81060-2:2018) + Amd1:2020 were recruited. BP measurements were conducted using the same-arm sequential method. The test device cuff was suitable for arm circumferences ranging from 22.0 cm to 42.0 cm.</p><p><strong>Results: </strong>Eighty-nine participants were initially recruited, 85 were evaluated after excluding 4 participants. The mean age of the participants was 48.5 ± 15.17 years. For validation criterion 1, the mean ± standard deviation (SD) of the differences between the test device and the reference BP measurements were 0.2 ± 5.74 mmHg for systolic BP and -0.9 ± 4.69 mmHg for diastolic BP. These results met the AAMI/ESH/ISO (ISO 81060-2:2018)+Amd1:2020 standard, which requires differences of ≤5 ± ≤8 mmHg. For validation criterion 2, the mean differences between the test device and the reference device were 0.2 ± 5.10 mmHg for systolic BP and -0.9 ± 4.30 mmHg for diastolic BP. This criterion was satisfied with criterion 2 of ≤6.95 mmHg for systolic BP and ≤6.88 mmHg for diastolic BP.</p><p><strong>Conclusion: </strong>The Omron J760 electronic BP monitor meets the requirements of the AAMI/ESH/ISO (ISO 81060-2:2018)+Amd 1:2020 validation standard.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2469264"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143482186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-03-31DOI: 10.1080/08037051.2025.2480608
Sverre E Kjeldsen, Mattias Brunström, Michel Burnier, Brent Egan, Krzysztof Narkiewicz, Reinhold Kreutz, Giuseppe Mancia
{"title":"Management of 'Elevated' blood pressure according to the 2024 European Society of Cardiology Guidelines: lack of supportive evidence and high risk of excessive treatment.","authors":"Sverre E Kjeldsen, Mattias Brunström, Michel Burnier, Brent Egan, Krzysztof Narkiewicz, Reinhold Kreutz, Giuseppe Mancia","doi":"10.1080/08037051.2025.2480608","DOIUrl":"10.1080/08037051.2025.2480608","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2480608"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143646936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-04-03DOI: 10.1080/08037051.2025.2487592
János Nemcsik, Enrique Rodilla, Fabiolucio Albini, Michael Doumas, Jean-Marc Boivin, Helga Gyöngyösi, Reinhold Kreutz, Rosa de Pinho
{"title":"Implementation of hypertension guidelines by general practitioner societies and the use of single pill combinations in Europe-results of the survey of the general practitioner nucleus of European society of hypertension.","authors":"János Nemcsik, Enrique Rodilla, Fabiolucio Albini, Michael Doumas, Jean-Marc Boivin, Helga Gyöngyösi, Reinhold Kreutz, Rosa de Pinho","doi":"10.1080/08037051.2025.2487592","DOIUrl":"10.1080/08037051.2025.2487592","url":null,"abstract":"<p><strong>Purpose: </strong>The implementation of hypertension guidelines into the everyday practice of general practitioners (GPs) have an outmost importance to provide optimal care for patients. The aim of our study was, on the one hand to gain insight about the relationship between hypertension societies and GP societies, and on the other hand, to get feedback about the use of single pill combinations (SPC) in each country, as an indicator of guideline implementation.</p><p><strong>Materials and methods: </strong>The European Society of Hypertension (ESH) GP Nucleus initiated a survey containing 17 questions about the existence and number of national hypertension and GP societies, the relationship between them and with pharmacists and nurse associations, the authors of national guidelines and the availability of SPCs. The survey was sent to the national hypertension society representatives of ESH. Additionally, data about the number of SPCs sold yearly was also checked using IQVIA database.</p><p><strong>Results: </strong>Responses were collected from 25 European countries. In most of the countries there is only one hypertension society (23/25) and one GP society (18/25), most of which having a relationship with each other (22/25). Of the countries with national hypertension guidelines most of them are written by the national hypertension society (45%) followed by the GP society (27%) or by public administration (27%). Two thirds of the national hypertension societies (16/25) have relationship with nurse societies and half of them (12/25) with pharmacists. In 65% (15/23) of the guidelines dual SPC therapy is recommended for treatment initiation however, marked differences are present in the number of yearly sold SPCs in different countries.</p><p><strong>Conclusions: </strong>National hypertension societies have remarkable impact on GPs for the management of hypertensive patients. However, improvement is needed in the collaboration with nurse and pharmacist societies and in some countries in the use of SPCs for hypertension therapy.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2487592"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143750426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Postoperative systemic arterial hypertension in infants with congenital heart diseases: prevalence and risk factors.","authors":"Xiaohong Chen, Yanling Chen, Lijie Zhao, Ruikun Zou, Yuan Ren, Xin Sun, Xinmeng Zhang, Haiyun Yuan, Yifei Wang","doi":"10.1080/08037051.2024.2436385","DOIUrl":"https://doi.org/10.1080/08037051.2024.2436385","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence rate and risk factors for systemic arterial hypertension in infants with congenital heart diseases.</p><p><strong>Methods: </strong>A retrospective cohort study of postoperative systemic arterial hypertension incidence in infants who underwent cardiac surgery was conducted. The primary diagnosis was retrieved. The general characteristics, surgical information, and blood pressure data at five periods were also collected. The five periods were at admission, 48 hours after cardiac surgery (postoperative), at discharge, at full-time, and at any time during hospitalisation. The risk factors for postoperative hypertension and hypertension at discharge were determined by multivariate logistic regression.</p><p><strong>Results: </strong>This study enrolled 1205 eligible infants. The age and weight at surgery were 27.0 (13.0, 59.0) days and 3.53 ± 0.96 kg, respectively. The prevalence rates of postoperative hypertension and hypertension at discharge were 12.8 (10.9-14.7)% and 6.9 (5.5-8.3)%, respectively. The incidence of postoperative hypertension varies greatly across different types of congenital heart diseases. A low weight <i>Z</i> score, preoperative hypertension, patent ductus arteriosus, and coarctation of the aorta were risk factors for postoperative hypertension, whereas transposition of the great arteries grouped with pulmonary atresia, pulmonary stenosis, and total anomalous pulmonary venous connection was a protective factor. The ventricular septal defect was a risk factor for postoperative hypertension but not for hypertension at discharge.</p><p><strong>Conclusions: </strong>The incidence of postoperative systemic arterial hypertension is high in infants after cardiac surgery. The prevalence of hypertension decreased at discharge. Prospective long-term follow-up studies are needed to delineate the natural history of hypertension in high-risk children.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"34 1","pages":"2436385"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-03-31DOI: 10.1080/08037051.2025.2481229
Alaa Sharfo, Astrid Lahn Sørensen, Emil Eik Nielsen, Ilan Esra Raymond, Anne Merete Boas Soja, Michael Hecht Olsen
{"title":"OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020.","authors":"Alaa Sharfo, Astrid Lahn Sørensen, Emil Eik Nielsen, Ilan Esra Raymond, Anne Merete Boas Soja, Michael Hecht Olsen","doi":"10.1080/08037051.2025.2481229","DOIUrl":"10.1080/08037051.2025.2481229","url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) is an increasing health problem globally. Profound sex-related differences have been observed regarding the cause, treatment, and prognosis of HF.</p><p><strong>Aim: </strong>To assess baseline predictors for achieving optimal medical treatment (OMT) and the prognostic importance of OMT for male and female patients who have attended a HF clinical program (HFCP).</p><p><strong>Methods: </strong>OPTIHEART was a retrospective study that included 870 consecutive patients with left ventricular ejection fraction (LVEF)≤40% discharged from HFCP in 2018, 2019 or 2020 and followed in registers for a mean of 1083(SD 11.3) days. OMT was defined as receiving an angiotensin-converting-enzyme-inhibitor (ACEi), angiotensin-receptor blocker (ARB) or angiotensin-II-receptor blocker and nephrylisin-inhibitor (ARNI) AND a betablocker (BB) both in doses ≥ 50% of target doses.</p><p><strong>Results: </strong>Achieving OMT was associated with male sex (OR: 2.05 95%CI 1.44-2.97; <i>p</i> < 0.0001) independently of younger age, higher diastolic blood pressure (DBP), and lower creatinine. A lower rate of 5-point MACE was associated with achieved OMT (HR: 0.67 95%CI 0.50-0.90; <i>p</i> = 0.007) independently of female sex (HR: 0.64 95%CI 0.48-0.84; <i>p</i> = 0.002), younger age, never smoking and NYHA ≤ 2. The beneficial effect of OMT was insignificantly more pronounced in patients with male sex, older age, higher creatinine, lower DBP, and body mass index ≤25kg/m<sup>2</sup>.</p><p><strong>Conclusion: </strong>OMT was more frequently achieved in patients with male sex independently of age, DBP, and creatinine. Achieving OMT was associated with less 5-point MACE independently of female sex, younger age, never smoking and NYHA ≤ 2.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2481229"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143656073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-03-10DOI: 10.1080/08037051.2025.2475314
Ahmed Naji Mansoor, Vatsalya Choudhary, Zain Mohammad Nasser, Muskan Jain, Dhruvikumari Dayanand Sharma, Mateo Jaramillo Villegas, Sujaritha Janarthanam, Muhammad Ayyan, Simran Ravindra Nimal, Huzaifa Ahmad Cheema, Muhammad Ehsan, Muhammad Aemaz Ur Rehman, Abdulqadir Nashwan, Sourbha S Dani
{"title":"More intensive versus conservative blood pressure lowering after endovascular therapy in stroke: a meta-analysis of randomised controlled trials.","authors":"Ahmed Naji Mansoor, Vatsalya Choudhary, Zain Mohammad Nasser, Muskan Jain, Dhruvikumari Dayanand Sharma, Mateo Jaramillo Villegas, Sujaritha Janarthanam, Muhammad Ayyan, Simran Ravindra Nimal, Huzaifa Ahmad Cheema, Muhammad Ehsan, Muhammad Aemaz Ur Rehman, Abdulqadir Nashwan, Sourbha S Dani","doi":"10.1080/08037051.2025.2475314","DOIUrl":"10.1080/08037051.2025.2475314","url":null,"abstract":"<p><strong>Background: </strong>The optimum systolic blood pressure (BP) after endovascular thrombectomy for acute ischaemic stroke is uncertain. We aimed to perform an updated meta-analysis of randomised controlled trials (RCTs) to evaluate the safety and efficacy of more intensive BP management compared to less intensive BP management.</p><p><strong>Methods: </strong>We searched various electronic databases to retrieve relevant RCTs on the clinical effects of more intensive BP management after endovascular thrombectomy compared to the less intensive management. We calculated odds ratios (ORs) with 95% confidence intervals (CIs) for dichotomous outcomes.</p><p><strong>Results: </strong>Our meta-analysis included four RCTs with a total of 1560 patients. More intensive BP management (<140 mmHg) was associated with a statistically significant decrease in the number of patients showing functional independence (modified Rankin scale [mRS] score = 0-2) at 90 days (OR 0.69; CI = 0.51-0.94). Regarding 90-day mortality, our pooled results showed no statistically significant difference between the two groups (OR 1.21; CI = 0.89-1.65). There was no statistically significant difference between the two groups regarding the incidence of intracerebral haemorrhage (ICH) (OR 1.09; CI = 0.85-1.39) and the incidence of symptomatic intracerebral haemorrhage (sICH) (OR 1.11; CI = 0.75-1.65).</p><p><strong>Conclusion: </strong>According to our meta-analysis, the intensive BP lowering group decreased the number of patients showing functional independence at 90 days. We found no benefit of the intensive lowering of BP on mortality rates and incidence of ICH compared to the conservative BP management. Future large-scale trials should focus on other interventions to improve prognosis in these patients.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2475314"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143540047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-12-01Epub Date: 2025-03-28DOI: 10.1080/08037051.2025.2483864
Shuoyan An, Zixiang Ye, Wuqiang Che, Yanxiang Gao, Xiaoyan Duo, Xingliang Li, Jiahui Li, Jingang Zheng
{"title":"Association between ACEI/ARB and short-term prognosis in dialysis patients with hypertension admitted to intensive care unit.","authors":"Shuoyan An, Zixiang Ye, Wuqiang Che, Yanxiang Gao, Xiaoyan Duo, Xingliang Li, Jiahui Li, Jingang Zheng","doi":"10.1080/08037051.2025.2483864","DOIUrl":"10.1080/08037051.2025.2483864","url":null,"abstract":"<p><strong>Introduction: </strong>To investigate the association between angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB) and short-term prognosis in dialysis patients with hypertension admitted to intensive care unit (ICU).</p><p><strong>Methods: </strong>Patients with a diagnosis of hypertension and dialysis who received antihypertensive agents during hospitalisation were included. Based on whether treated with ACEI/ARB, patients were divided to ACEI/ARB group and non- ACEI/ARB group. In-hospital mortality and 30-day all-cause mortality were compared between the two groups in the overall participants and after propensity score matching.</p><p><strong>Results: </strong>The study included 647 patients, among which 227 (34.70%) were treated with ACEI/ARB. Compared to the non-ACEI/ARB group, fewer patients in the ACEI/ARB group suffered from atrial fibrillation/flutter (17.2% vs 31.9%, <i>p</i> < 0.001). The overall hospital mortality rate was 5.1%, and 9.0% of patients died during the 30-day follow-up period. ACEI/ARB group were with better clinical outcomes during hospitalisation (2.2% vs 6.7%, <i>p</i> = 0.023) and after 30-day follow-up (5.3% vs 11.0%, <i>p</i> = 0.016). ACEI/ARB treatment was independently associated with lower risk of hospital mortality (OR 0.24, 96% CI: 0.051 - 0.82, <i>p</i> = 0.038) and 30-day mortality (HR 0.36, 95% CI:0.15-0.89, <i>p</i> = 0.029) after adjusting confounding factors. After propensity score matching (PSM, 112 pairs), the ACEI/ARB group showed higher in-hospital (99.1% vs 91.1%, <i>p</i> = 0.013) and 30-day (95.5% vs 88.4%, <i>p</i> = 0.048) survival rates compared to the control group. ACEI/ARB was identified as an independent protector for 30-day mortality in the matched cohort (HR 0.33, 95% CI: 0.11-0.95, <i>p</i> = 0.041).</p><p><strong>Conclusion: </strong>ACEI/ARB treatment showed a significant association with improved in-hospital and 30-day outcomes in dialysis patients with hypertension in the ICU.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2483864"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blood PressurePub Date : 2025-04-07DOI: 10.1080/08037051.2025.2490592
Sari Luthfiyah, Triwiyanto Triwiyanto, Adin Muafiro
{"title":"Letter to Editor: Validating the Accuracy of Omron J760 Electronic Blood Pressure Monitor in the General Population According to AAMI/ESH/ISO (ISO 81060-2:2018) + AMD1:2020.","authors":"Sari Luthfiyah, Triwiyanto Triwiyanto, Adin Muafiro","doi":"10.1080/08037051.2025.2490592","DOIUrl":"https://doi.org/10.1080/08037051.2025.2490592","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"1-2"},"PeriodicalIF":1.8,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}